Serum placental isoferritin and breast cancer prognosis
β Scribed by M. Stierer; H. R. Rosen; Ch. Moroz
- Book ID
- 105318001
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 83 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A component of placental isoferritin, p43, is an immuno-regulatory protein associated with suppression of the immune system. Maternal serum p43 levels increase throughout pregnancy and low serum levels have been associated with various pathological pregnancies, particularly those with a defect of pl
## Abstract Although certain risk factors for breast cancer incidence may also effect survival, findings have been inconsistent and the longβterm role of childbirth is unknown. We studied the influence of number and timing of births on breast cancer prognosis prospectively. From 1958 to 1997, altog
Analysis of five-year disease-free survival rates in 608 women with operable breast cancer revealed that the reproductive history is a significant prognostic determinant. Overall parous women had a significantly higher cumulative five-year disease-free survival rate (a%), compared to the nulliparous